EpilepsyGTx et Viralgen collaborent pour faire progresser le programme de thérapie génique à base d'AAV contre l'épilepsie, en vue d'un premier essai clinique chez l'humain PR Newswire (Press Release) 13:52 Wed, 09 Sep
EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy programme for epilepsy Pharmaceutical Field 12:46 Wed, 09 Sep
Bayer AG: AskBio's Viralgen,EpilepsyGTx Partner To Advance AAV Gene Therapy For Epilepsy RTT News 12:38 Wed, 09 Sep
EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy program for epilepsy ahead of first-in-human trial News-Medical.Net 12:27 Wed, 09 Sep
EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy programme for epilepsy ahead of first-in-human trial PR Newswire (Press Release) 09:07 Wed, 09 Sep
